EyePoint (EYPT) Asset Utilization Ratio (2011 - 2026)

EyePoint (EYPT) reported Asset Utilization Ratio of 0.02 for Q1 2026, down 83.73% on a YoY basis from 0.14 in Q1 2025, and down 77.09% sequentially from 0.1 in Q4 2025.

EyePoint (EYPT) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

EyePoint (EYPT) has 16 years of Asset Utilization Ratio data on file, last reported at 0.02 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio fell 83.73% year-over-year to 0.02; the trailing twelve-month figure through Mar 2026 stood at 0.02 (down 83.73% YoY), and the FY2025 full-year result was 0.08, down 28.32% from the prior year.
  • Asset Utilization Ratio fell to 0.02 in Q1 2026, from 0.1 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.25 in Q3 2023 to a low of 0.02 in Q1 2026.
  • A 5-year average of 0.16 and a median of 0.15 in 2024 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio soared 55.08% in 2023 and plunged 83.73% in 2026, its largest moves.
  • Tracing EYPT's Asset Utilization Ratio over 5 years: stood at 0.21 in 2022, then declined by 13.53% to 0.18 in 2023, then sank by 32.65% to 0.12 in 2024, then slipped by 15.29% to 0.1 in 2025, then tumbled by 77.09% to 0.02 in 2026.
  • Business Quant data shows EYPT's Asset Utilization Ratio at 0.02 in Q1 2026, 0.1 in Q4 2025, and 0.15 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 0.02

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02
Dec 31, 2025 0.10
Sep 30, 2025 0.15
Jun 30, 2025 0.16
Mar 31, 2025 0.14
Dec 31, 2024 0.12
Sep 30, 2024 0.15
Jun 30, 2024 0.15
Mar 31, 2024 0.15
Dec 31, 2023 0.18
Sep 30, 2023 0.25
Jun 30, 2023 0.23
Mar 31, 2023 0.24
Dec 31, 2022 0.21
Sep 30, 2022 0.19
Jun 30, 2022 0.17
Mar 31, 2022 0.15
Dec 31, 2021 0.17
Sep 30, 2021 0.19
Jun 30, 2021 0.21